Rpo »

Atea Pharmaceuticals shares owned by Rpo

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Rpo from 13F filings

Historical chart of Rpo investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Rpo consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Rpo

Quarter filed Position value Share count Share price at filing
2023-12-31 $40k 13k 3.05

More positions owned by Rpo

stock
Abrdn Healthcare Investors Sh Ben Int (HQH)
Nuveen Multi-Strategy Income & Growth (JPC)
Abrdn Life Sciences Investor Sh Ben Int (HQL)
Flaherty & Crumrine/Claymore Preferred S (FFC)
Blackrock Science & Technolo Shs Ben Int (BSTZ)
Flaherty & Crumrine Dynamic SHS (DFP)
Gabelli Dividend & Income Trust (GDV)
Blackrock Muniyield Fund (MYD)
Calamos Global Dynamic Income Fund (CHW)
Duff & Phelps Global (DPG)
Royce Value Trust (RVT)
Blackrock Munivest Fund II (MVT)
Boulder Growth & Income Fund (STEW)
Capri Holdings SHS (CPRI)

View all positions for Rpo

Top funds holding Atea Pharmaceuticals

EcoR1 Capital
BML Capital Management
Vanguard Group
Tang Capital Management
Federated Investors
Charles Schwab Investment Management
Jacobs Levy Equity Management
Newtyn Management
Banque Pictet & Cie Sa
Two Sigma Advisers
CM Management
Bank of America Corporation
Bank of New York Mellon
Goldman Sachs Group
Barclays

View all funds holding Atea Pharmaceuticals